Eduardo Carbajo-Perez
Overview
Explore the profile of Eduardo Carbajo-Perez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alvarez-Garcia O, Garcia-Lopez E, Loredo V, Gil-Pena H, Rodriguez-Suarez J, Ordonez F, et al.
Kidney Int
. 2010 Jun;
78(6):561-8.
PMID: 20555322
Rapamycin, a potent immunosuppressant used in renal transplantation, has been reported to impair longitudinal growth in experimental studies. Rapamycin is both antiproliferative and antiangiogenic; therefore, it has the potential to...
2.
Gil-Pena H, Garcia-Lopez E, Alvarez-Garcia O, Loredo V, Carbajo-Perez E, Ordonez F, et al.
Am J Physiol Renal Physiol
. 2009 Jul;
297(3):F639-45.
PMID: 19587145
Hypokalemic tubular disorders may lead to growth retardation which is resistant to growth hormone (GH) treatment. The mechanism of these alterations is unknown. Weaning female rats were grouped (n =...
3.
Gil H, Lozano J, Alvarez-Garcia O, Secades-Vazquez P, Rodriguez-Suarez J, Garcia-Lopez E, et al.
Growth Horm IGF Res
. 2008 Mar;
18(4):353-9.
PMID: 18331806
Objectives: Treatment with growth hormone (GH) improves growth retardation of chronic renal failure. cDNA microarrays were used to investigate GH-induced modifications in gene expression in the tibial growth plate of...
4.
Alvarez-Garcia O, Carbajo-Perez E, Garcia E, Gil H, Molinos I, Rodriguez J, et al.
Pediatr Nephrol
. 2007 Mar;
22(7):954-61.
PMID: 17370095
Rapamycin is a potent immunosuppressant with antitumoral properties widely used in the field of renal transplantation. To test the hypothesis that the antiproliferative and antiangiogenic activity of rapamycin interferes with...
5.
Alvarez-Garcia O, Garcia-Lopez E, Rodriguez J, Gil-Pena H, Molinos I, Carbajo-Perez E, et al.
Nephrol Dial Transplant
. 2007 Feb;
22(5):1309-13.
PMID: 17317714
Background: Ghrelin administration stimulates appetite and growth hormone (GH) secretion. Whether these effects are preserved in young individuals with chronic renal failure (CRF) and their potential benefit on growth is...
6.
Santos F, Carbajo-Perez E, Rodriguez J, Fernandez-Fuente M, Molinos I, Amil B, et al.
Pediatr Nephrol
. 2004 Nov;
20(3):330-4.
PMID: 15549411
Chronic renal failure modifies the morphology and dynamics of the growth plate (GP) of long bones. In young uremic rats, the height of cartilage columns of GP may vary markedly....
7.
Amil B, Fernandez-Fuente M, Molinos I, Rodriguez J, Carbajo-Perez E, Garcia E, et al.
Kidney Int
. 2004 Jun;
66(1):51-9.
PMID: 15200412
Background: Growth retardation of chronic renal failure is associated with alterations in the growth plate suggestive of a disturbed chondrocyte maturation process and abnormal vascular invasion at the chondro-osseous interphase....
8.
Fernandez-Fuente M, Santos F, Carbajo-Perez E, Rodriguez J, Weruaga A, Amil B, et al.
Pediatr Nephrol
. 2003 Dec;
19(2):187-92.
PMID: 14677056
To understand the changes induced by uremia in the epiphyseal growth plate, two studies were performed in young rats. In study 1, the morphological features of the tibial growth cartilage...
9.
Medina A, Fernandez-Fuente M, Carbajo-Perez E, Santos F, Amil B, Rodriguez J, et al.
Pediatr Nephrol
. 2002 Dec;
17(12):1005-12.
PMID: 12478349
The outcome of ischemic acute renal failure (IARF) is better in young than adult rats. Insulin-like growth factor I (IGF-I) treatment may increase mortality of adult rats with IARF, probably...
10.
Latta K, Krieg Jr R, Carbajo-Perez E, Carbajo S, Chan J
Life Sci
. 2002 Aug;
71(16):1951-60.
PMID: 12175709
Deflazacort is a relatively new glucocorticoid with significant immunosuppressant activity and presumably fewer side effects. The present study was designed to compare the effects of deflazacort on the proliferative activity...